Clinical trials
Trials in South Africa with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
133 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 11 |
| 2018 | 8 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 12 |
| 2023 | 6 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 133 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Cape Town | 23 |
| University of Stellenbosch | 8 |
| University of Witwatersrand, South Africa | 5 |
| Desmond Tutu HIV Centre | 3 |
| International Atomic Energy Agency | 3 |
| The Aurum Institute NPC | 3 |
| AtheroGenics | 2 |
| Biopure Corporation | 2 |
| Brigham and Women's Hospital | 2 |
| Cleveland Chiropractic College | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 15 |
| Tuberculosis | 13 |
| Acquired Immunodeficiency Syndrome | 8 |
| COVID-19 | 7 |
| Tuberculosis, Pulmonary | 6 |
| Coronary Artery Disease | 4 |
| Tuberculosis, Multidrug-Resistant | 4 |
| Breast Neoplasms | 3 |
| Malnutrition | 3 |
| Cardiovascular Diseases | 2 |
Trials
Showing 26 to 50 of 133. Each trial links to its page on Pharma Observatory.
33 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.